Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.

@article{Hugosson2010MortalityRF,
  title={Mortality results from the G{\"o}teborg randomised population-based prostate-cancer screening trial.},
  author={Jonas Hugosson and Sigrid Viktoria Carlsson and Gunnar Aus and Svante Bergdahl and Ali Khatami and P{\"a}r Lodding and Carl-Gustaf Pihl and Johan Stranne and Erik Holmberg and Hans G Lilja},
  journal={The Lancet. Oncology},
  year={2010},
  volume={11 8},
  pages={725-32}
}
BACKGROUND Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate. METHODS In December, 1994, 20,000 men born between 1930 and 1944, randomly sampled from the population register, were randomised by computer in a 1:1 ratio to either a… CONTINUE READING
Highly Influential
This paper has highly influenced 21 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 385 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Similar Papers

Loading similar papers…